In the general population, key hormonal biomarkers for the assessment of hypogonadism include testosterone, LH, FSH, GnRH (discussed above), as well as anti-Müllerian hormone (AMH), inhibin B, and insulin-like factor 3 (INSL-3) [105]. This evidence concerns the gene AMH and hypogonadism.